China SXT Pharmaceuticals, Inc.
For the period ended Sep 30, 2024. Filed Mar 28, 2025.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Sep 30, 2024 · Filed Mar 28, 2025
Use the contents to explore the available documents and sections.
Contents
EX-99.2 · 2023 Reverse stock split
2023 Reverse stock split
On October 5, 2023, the Company effected a one-for-twenty-five (1-25) reverse split of its ordinary shares, such that the number of the Company’s authorized preferred and ordinary shares is unchanged, which will remain as unlimited, and the par value of each ordinary share is increased from US$0.08 to US$2. In addition, all shares, options and any other securities of the Company outstanding immediately prior to the reverse stock split were retroactively applied by dividing the number of ordinary shares into which the options and other securities are exercisable by 25 and multiplying the exercise price thereof by 25, as a result of the reverse stock split.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.